The Teenager's Opioid Prescription and the Instagram Post
Dr. Chen extracts a partially impacted third molar in a 15-year-old patient at a Merrillville office. He prescribes 20 tablets of oxycodone 5 mg, tells the parent to use what is left for the younger brother's future toothache, and does not check the Indiana prescription drug monitoring program because the patient is a minor. He also posts a before-and-after photo of the patient's smile on the practice Instagram with the caption Another perfect wisdom tooth case! The patient's face is not visible, but the caption says 15-year-old. The parent signed a general office financial and consent form that includes a line permitting use of images for marketing. The next day the parent calls angry and asks for the post to be taken down. The office manager says the consent covers it. Dr. Chen asks whether he has a problem.
1. Evaluate Dr. Chen's opioid prescribing and the advice to save leftover tablets for the younger brother.
Read the worked answer
Dr. Chen has a prescribing problem that is independent of the patient's age. Opioid prescribing must be for a legitimate medical purpose, in an appropriate quantity, with appropriate instructions, and with documented informed consent and follow-up. Telling a parent to save leftover oxycodone for a sibling's future toothache is not a legitimate prescription for that sibling: there is no patient relationship, no examination, no diagnosis, and no individualized risk assessment. It also invites diversion and unsafe use.
Indiana prescribers have PDMP obligations and opioid-prescribing rules that apply according to the specific circumstance, and a prescriber should not assume that minor status eliminates the need to check when the rule requires it. Dr. Chen should verify the current requirement rather than rely on his assumption. The record should show the indication, dose, quantity, instructions, discussion of risks, and plan for unused medication. The office should correct the advice to the parent immediately, counsel on safe disposal, and not repeat the recommendation. This conduct can support board discipline for unprofessional conduct and prescribing violations.
2. Does the signed general marketing line authorize the Instagram post? What should Dr. Chen do now?
Read the worked answer
Probably not. A line buried in a financial and general consent form is unlikely to be a valid HIPAA authorization for marketing. A valid authorization is specific, written in plain language, identifies the information to be used, states the purpose, identifies the recipient, and tells the patient how to revoke it. The patient is a minor, so the parent's authorization is ordinarily required, but the parent can also revoke it. The caption saying 15-year-old, combined with the procedure and the practice location, may make the patient identifiable even without a face.
Dr. Chen should take the post down promptly, confirm in writing that it was removed, and document the parent's request and the office's response. He should not argue that the general consent covers it. He should review the office's social media and authorization process, obtain specific authorizations for any future marketing, and avoid captions that combine age, procedure, and identifying details.
3. What board and risk-management issues does this scenario present beyond the post itself?
Read the worked answer
The board issues are not limited to social media. The opioid advice and the failure to verify PDMP obligations can be treated as prescribing and professional-conduct violations. The Instagram post can be treated as a confidentiality and informed-consent failure. The combination matters because a board complaint often arises from a patient relationship problem, not from a single isolated technical error.
Dr. Chen should preserve the original records, including the prescription and the consent form, and should not alter them after the complaint. He should speak with the parent honestly, correct the misinformation about leftover opioids, and offer a follow-up appointment if the extraction site needs evaluation. He should consider consulting a health care attorney and his malpractice carrier if a board complaint is filed. He should also train staff that production pressure, marketing, and convenience do not override prescribing and privacy rules.